Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)

Landon Pediatric Foundation65 enrolled

Overview

To demonstrate differences in tidal breathing patterns measured by SLP(Structured Light Plethysmography) between healthy subjects and COPD (chronic obstructive pulmonary disease). The correlation between SLP parameters and standard lung function parameters measured by body box and spirometry will also be assessed. Trends in SLP breathing patterns between the different GOLD (Global Initiative for Chronic Obstructive Lung Disease) stages of COPD, and between those and healthy subjects, will be investigated to assess whether SLP can detect differences between groups.

Structured light plethysmography (SLP) is a novel, non-contact method for assessing quiet 'tidal' breathing. A number of studies have reported the effects of conditions such as chronic obstructive pulmonary disease (COPD) on tidal breathing patterns, and a previous study has shown that SLP is able to detect differences in ten tidal breathing patterns between healthy subjects and patients with COPD. In this present study, the investigators will aim to confirm the previous findings and also to examine the relationship between SLP tidal breathing parameters and traditional measurements of lung function measured by spirometry and body box plethysmograph. The correlation between SLP parameters with lung Function parameters measured by spirometry and body box plethysmography: forced expiratory volume in one second (FEV1); Forced vital capacity (FVC), FEV1/FVC (forced expiratory volume in one second/forced vital capacity); total lung capacity (TLC) and residual volume (RV). Trends in tidal breathing patterns between varying severities of COPD (based on the (Global initiative for lung disease (GOLD) grading system.

Study Type

INTERVENTIONAL

Allocation

NON_RANDOMIZED

Purpose

SCREENING

Masking

NONE

Enrollment

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

Thora-3DiDEVICE

Device that uses a grid of structured light to measure chest and abdominal wall movement

Body PlethysmographyDEVICE

A pulmonary function test (PFT) for measuring total lung volume.

SpirometryDEVICE

A pulmonary function tests (PFT) for measuring maximal forced expiratory flow and volume.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 80 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Age range 18-80 years, * BMI range 18-40 kg/m2 * Patients diagnosed, or suspected, with COPD or normal subjects with no previous or current diagnosis of respiratory disease Exclusion Criteria: * Patient unable to sit in an upright position for required period of time * Patients with significant co morbidities (assessed by the clinician at screening only): * Significant unilateral lung disease e.g. pneumonectomy * Chest wall or spinal deformity e.g. scoliosis * Obstructive sleep apnea (OSA), Apnoea hypopnoea index \> 30 (if known) * BMI\>40 * Inability to consent/comply with trial protocol * Presence of an acute disease process that might interfere with test performance, e.g. Nausea, vomiting, persistent coughing)

Locations (1)

Ventura County Medical Center

Ventura, California, United States

Outcomes

Primary Outcomes

Difference in SLP Breath Timing indices measured in seconds and between Patients and Healthy Subjects

SLP breathing parameters derived from the movement of the thoracoabdominal (TA) wall during tidal breathing

Time frame: Baseline

Difference in SLP derived Relative Contribution (measured in %) between Patients and Healthy Subjects

SLP breathing parameters derived from the movement of the thoracoabdominal (TA) wall during tidal breathing that describes the contribution of a region of the thoracoabdominal wall to total displacement

Time frame: Baseline

Difference in SLP derived Phase (measured in degrees) between Patients and Healthy Subjects

Time frame: Baseline

Difference in SLP derived displacement rate derived parameters (measured in distance per second) between Patients and Healthy Subjects

SLP breathing parameters derived from the trace of displacement rate over time of the thoracoabdominal (TA) wall during tidal breathing

Time frame: Baseline

Difference in SLP displacement rate derived ratios between Patients and Healthy Subjects (measured in distance per second) between Patients and Healthy Subjects

SLP breathing parameters ratios derived from the trace of displacement rate over time of the thoracoabdominal (TA) wall during tidal breathing

Time frame: Baseline

Correlation between SLP parameters with lung Function parameters measured by spirometry and body box plethysmography ( FEV1; FEV1/FVC; TLC and RV)

SLP breathing parameters ratios derived from the trace of displacement rate over time of the thoracoabdominal (TA) wall during tidal breathing correlated with lung function measured by body plethysmography and spirometry

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.

Thora-3DI™ for Evaluation of Severity of Chronic Obstructive Pulmonary Disease (COPD)

Overview

Conditions

Interventions

Eligibility

Locations (1)

Outcomes

Primary Outcomes

Secondary Outcomes